Epigenetic dedifferentiation of somatic cells into pluripotency: Cellular alchemy in the age of regenerative medicine?

Regenerative Medicine

Volumn 2, Issue 5, 2007, Pages 795-816

  Oliveri, Roberto S ^a  

^a Rigshospitalet   (Denmark)

Author keywords

Cell therapy; Cloning; Dedifferentiation; DNA demethylation; Epigenetics; Human embryonic stem cells; Plasticity; Pluripotency; Regenerative medicine; Reprogramming; Totipotency

Indexed keywords

DNA METHYLTRANSFERASE; HISTONE ACETYLTRANSFERASE; HLA ANTIGEN; INTERLEUKIN 2 RECEPTOR; MITOCHONDRIAL DNA; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR CDX2; TRANSCRIPTION FACTOR SOX2;

ACETYLATION; BLASTOCYST; CELL DIFFERENTIATION; CELL FUSION; CELL NUCLEUS TRANSPLANTATION; CELL PROLIFERATION; CELL SPECIFICITY; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMOSOME LOSS; CYTOPLASM; DEMETHYLATION; DNA METHYLATION; DNA SEQUENCE; EMBRYONIC STEM CELL; EPIGENETICS; FERTILIZATION IN VITRO; FIBROBLAST; GENOME; HUMAN; HUMAN CLONING; MAJOR HISTOCOMPATIBILITY COMPLEX; MEDICAL ETHICS; METAPHASE; NONHUMAN; NUCLEOSOME; OOCYTE DONATION; PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REVIEW; SOMATIC CELL THERAPY; X CHROMOSOME;

ANIMALS; CELL DIFFERENTIATION; CELL FUSION; EPIGENESIS, GENETIC; FORECASTING; HUMANS; MODELS, BIOLOGICAL; NUCLEAR REPROGRAMMING; NUCLEAR TRANSFER TECHNIQUES; PLURIPOTENT STEM CELLS; REGENERATIVE MEDICINE;

EID: 35048891436     PISSN: 17460751     EISSN: None     Source Type: Journal    
DOI: 10.2217/17460751.2.5.795     Document Type: Review

References (145)

1. Thomson JA, Itskovitz-Eldor J, Shapiro SS et al.: Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147 (1998).
2. Rideout WM III, Hochedlinger K, Kyba M, Daley GQ, Jaenisch R: Correction of a genetic defect by nuclear transplantation and combined cell and gene therapy. Cell 109, 17-27 (2002).
3. Wu LC, Sun CW, Ryan TM et al.: Correction of sickle cell disease by homologous recombination in embryonic stem cells. Blood 108, 1183-1188 (2006).
4. Westphal H: Restoring stemness. Differentiation 73, 447-451 (2005).
5. Alberto R, Campbell KH, Johnson AD: Reprogramming somatic cells into stem cells. Reproduction 132, 709-720 (2006).
6. Hochedlinger K, Jaenisch R: Nuclear reprogramming and pluripotency. Nature 441, 1061-1067 (2006).
7. Collas P, Gammelsaeter R: Novel approaches to epigenetic reprogramming of somatic cells. Cloning Stem Cells 9, 26-32 (2007).
8. Stevens LC, Varnum DS: The development of teratomas from parthenogenetically activated ovarian mouse eggs. Dev. Biol. 37, 369-380 (1974).
9. Lavker RM, Sun TT: Heterogeneity in epidermal basal keratinocytes: morphological and functional correlations. Sciece 215, 1239-1241 (1982).
10. Gage FH, Coates PW, Palmer TD et al.: Survival and differentiation of adult neuronal progenitor cells transplanted to the adult brain. Proc. Natl Acad. Sci. USA 92, 11879-11883 (1995).
11. Alison M, Sarraf C: Hepatic stem cells. J. Hepatol. 29, 676-682 (1998).
12. Reubinoff BE, Itsykson P, Turetsky T et al.: Neural progenitors from human embryonic stem cells. Nat. Biotechnol. 19, 1134-1140 (2001).
13. Kehat I, Kenyagin-Karsenti D, Snir M et al.: Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J. Clin. Invest 108, 407-414 (2001).
14. Lund RD, Wang S, Klimanskaya I et al.: Human embryonic stem cell-derived cells rescue visual function in dystrophic RCS rats. Cloning Stem Cells 8, 189-199 (2006).
15. Nayernia K, Nolte J, Michelmann HW et al.: In vitro-differentiated embryonic stem cells give rise to male gametes that can generate offspring mice. Dev. Cell 11, 125-132 (2006).
16. Wang D, Haviland DL, Burns AR, Zsigmond E, Wetsel RA: A pure population of lung alveolar epithelial type II cells derived from human embryonic stem cells. Proc Natl Acad. Sci. USA 104, 4449-4454 (2007).
17. Wang ZZ, Au P, Chen T et al.: Endothelial cells derived from human embryonic stem cells form durable blood vessels in vivo. Nat. Biotechnol. 25, 317-318 (2007).
18. Zwaka TP, Thomson JA: A germ cell origin of embryonic stem cells? Development 132, 227-233 (2005).
19. Grinnemo KH, Kumagai-Braesch M, Mansson-Broberg A et al.: Human embryonic stem cells are immunogenic in allogeneic and xenogeneic settings. Reprod. Biomed. Online. 13, 712-724 (2006).
20. Grusby MJ, Auchincloss H Jr, Lee R.et al.: Mice lacking major histocompatibility complex class I and class II molecules. Proc. Natl Acad. Sci. USA 90, 3913-3917 (1993).
21. Bradley JA, Bolton EM, Pedersen RA: Stem cell medicine encounters the immune system. Nat. Rev. Immunol. 2, 859-871 (2002).
22. Taylor CJ, Bolton EM, Pocock S et al.: Banking on human embryonic stem cells: estimating the number of donor cell lines needed for HLA matching. Lancet 366, 2019-2025 (2005).
23. Fishman JA, Rubin RH: Infection in organ-transplant recipients. N. Engl. J. Med. 338, 1741-1751 (1998).
24. Euvrard S, Kanitakis J, Claudy A: Skin cancers after organ transplantation. N. Engl. J. Med. 348, 1681-1691 (2003).
25. Russo VEA, Martienssen RA, Riggs AD: Epigenetic mechanisms of gene regulation. Cold Spring Harbour Laboratory Press, Plainview, NY, USA (1996).
26. Waddington CH: The strategy of the genes. Allen & Unwin, London, UK (1957).
27. Kornberg RD: Chromatin structure: a repeating unit of histones and DNA. Science 184, 868-871 (1974).
28. Shiota K: DNA methylation profiles of CpG islands for cellular differentiation and development in mammals. Cytogenet. Genome Res. 105, 325-334 (2004).
29. Santos F, Hendrich B, Reik W, Dean W: Dynamic reprogramming of DNA methylation in the early mouse embryo. Dev. Biol. 241, 172-182 (2002).
30. Kouzarides T: Chromatin modifications and their function. Cell 128, 693-705 (2007).
31. Maher B: The nucleosome untangled. The Scientist 20, 35-41 (2006).
32. Vignali M, Hassan AH, Neely KE, Workman JL: ATP-dependent chromatin-remodeling complexes. Mol. Cell Biol. 20, 1899-1910 (2000).
33. Kikyo N, Wade PA, Guschin D, Ge H, Wolffe AP: Active remodeling of somatic nuclei in egg cytoplasm by the nucleosomal ATPase ISWI. Science 289, 2360-2362 (2000).
34. Jones PL, Veenstra GJ, Wade PA et al.: Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat. Genet. 19, 187-191 (1998).
35. Nan X, Ng HH, Johnson CA et al.: Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393, 386-389 (1998).
36. Weismann A: Des Keimplasma - eine Theorie der Verenbung. Gustav Fischer, Jena, Germany (1882).
37. Wilmut I, Schnieke AE, McWhir J, Kind AJ, Campbell KH: Viable offspring derived from fetal and adult mammalian cells. Nature 385, 810-813 (1997).
38. Briggs R, King TJ: Transplantation of living nuclei from blastula cells into enucleated frogs eggs. Proc. Natl Acad Sci. USA 38, 455-463 (1952).
39. Briggs R, King TJ: Changes in the nuclei of differentiating endoderm cells as revealed by nuclear transplantation. J. Morphol. 100, 269-311 (1957).
40. Gurdon JB: The developmental capacity of nuclei taken from intestinal epithelium cells of feeding tadpoles. J. Embryol. Exp. Morpbol. 10, 622-640 (1962).
41. Willadsen SM: Nuclear transplantation in sheep embryos. Nature 320, 63-65 (1986).
42. Wakayama T, Perry AC, Zuccotti M, Johnson KR, Yanagimachi R: Full-term development of mice from enucleated oocytes injected with cumulus cell nuclei. Nature 394, 369-374 (1998).
43. Tatham BG, Dowsing AT, Trounson AO: Enucleation by centrifugation of in vitro- matured bovine oocytes for use in nuclear transfer. Biol. Reprod. 53, 1088-1094 (1995).
44. Vajta G, Lewis IM, Hyttel P, Thouas GA, Trounson AO: Somatic cell cloning without micromanipulators. Cloning 3, 89-95 (2001).
45. Cibelli JB, Lanza RP, Campbell KH, West MD: Principles of cloning. Academic Press, San Diego, CA, USA (2002).
46. Kang YK, Koo DB, Park JS et al.: Aberrant methylation of donor genome in cloned bovine embryos. Nat. Genet. 28, 173-177 (2001).
47. Dean W, Santos F, Stojkovic M et al.: Conservation of methylation reprogramming in mammalian development: aberrant reprogramming in cloned embryos. Proc. Nat/Acad. Sci. USA 98, 13734-13738 (2001).
48. Cibelli JB, Kiessling AA, Cunniff K et al.: Somatic cell nuclear transfer in humans: Pronuclear and early embryonic development. J. Reg. Med. 2, 25-31 (2001).
49. Lu C, Lin G, Xie C et al.: Reconstruction of human embry9s derived from somatic cells. Chinese Sci. Bull. 48, 1840-1843 (2003).
50. Cyranoski D: Verdict: Hwang's human stem cells were all fakes. Nature 439, 122-123 (2006).
51. Lee BC, Kim MK, Jang G et al.: Dogs cloned from adult somatic cells. Nature 436, 641 (2005).
52. Lee JB, Park C: Molecular genetics: verification that Snuppy Is a clone. Nature 440, E2-E3 (2006).
53. Lavoir MC, Weier J, Conaghan J, Pedersen RA: Poor development of human nuclear transfer embryos using failed fertilized oocytes. Reprod. Biomed. Online. 11, 740-744 (2005).
54. Kang YK, Koo DB, Park JS et al.: Influence of oocyte nuclei on demethylation of donor genome in cloned bovine embryos. FFBS Lett. 499, 55-58 (2001).
55. Simerly C, Dominko T, Navara C et al.: Molecular correlates of primate nuclear transfer failures. Science 300, 297 (2003).
56. Humpherys D, Eggan K, Akutsu H et al.: Abnormal gene expression in cloned mice derived from embryonic stem cell and cumulus cell nuclei. Proc. Natl Acad. Sci. USA 99(20), 12889-12894 (2002).
57. Eggan K, Akutsu H, Hochedlinger K et al.: X-Chromosome inactivation in cloned mouse embryos. Science 290, 1578-1581 (2000).
58. Xue F, Tian XC, Du F et al.: Aberrant patterns of X chromosome inactivation in bovine clones. Nat. Genet. 31, 216-220 (2002).
59. Nolen LD, Gao S, Han Z et al.: X chromosome reactivation and regulation in cloned embryos. Dev. Biol. 279, 525-540 (2005).
60. Mann MR, Lee SS, Doherty AS et al.: Selective loss of imprinting in the placenta following preimplantation development in culture. Development 131, 3727-3735 (2004).
61. Brambrink T, Hochedlinger K, Bell G, Jaenisch R: ES cells derived from cloned and fertilized blastocysts are transcriptionally and functionally indistinguishable. Proc. Natl Acad. Sci. USA 103, 933-938 (2006).
62. Hurlbut WB: Altered nuclear transfer as a morally acceptable means for the procurement of human embryonic stem cells. Perspect. Biol. Med. 48, 211-228 (2005).
63. The President's Council on Bioethics: Monitoring stem cell research (2004).
64. Strumpf D, Mao CA, Yamanaka Y et al.: Cdx2 is required for correct cell fate specification and differentiation of trophectoderm in the mouse blastocyst. Development 132, 2093-2102 (2005).
65. Meissner A, Jaenisch R: Generation of nuclear transfer-derived pluripotent ES cells from cloned Cdx2-deficient blastoysts. Nature 439, 212-215 (2006).
66. Melton DA, Daley GQ, Jennings CG: Altered nuclear transfer in stem-cell research - a flawed proposal. N. Engl. J. Med. 351, 2791-2792 (2004).
67. Solter D: Politically correct human embryonic stem cells? N. Fngl. J. Med. 353, 2321-2323 (2005).
68. Solter D: Politically correct human embryonic stem cells? - Reply. N Engl. J Med. 354, 1209 (2006).
69. Thompson C: Why we should, in fact, pay for egg donation. Regenerative Med. 2, 203-209 (2007).
70. Chen Y, He ZX, Liu A et al.: Embryonic stem cells generated by nuclear transfer of human somatic nuclei into rabbit oocytes. Cell Res. 13, 251-263 (2003).
71. St John JC, Lloyd RE, Bowles EJ, Thomas EC, El SS: The consequences of nuclear transfer for mammalian foetal development and offspring survival. A mitochondrial DNA perspective. Reproduction 127, 631-641 (2004).
72. Chang KH, Lim JM, Kang SK et al.: Blastocyst formation, karyotype, and mitochondrial DNA of interspecies embryos derived from nuclear transfer of human cord fibroblasts into enucleated bovine oocytes. Fertil. Steril. 80, 1380-1387 (2003).
73. Dennis C: Chinese fusion method promises fresh route to human stem cells. Nature 424, 711 (2003).
74. Kenyon L, Moraes CT: Expanding the functional human mitochondrial DNA database by the establishment of primate xenomitochondrial cybrids. Proc. Natl Acad. Sci. USA 94, 9131-9135 (1997).
75. Graur D, Duret L, Gouy M: Phylogenetic position of the order Lagomorpha (rabbits, hares and allies). Nature 379, 333-335 (1996).
76. Kumar S, Hedges SB: A molecular timescale for vertebrate evolution. Nature, 392, 917-920 (1998).
77. Blanchette M, Green ED, Miller W, Haussier D: Reconstructing large regions of an ancestral mammalian genome in silico. Genome Res. 14, 2412-2423 (2004).
78. Inter-species embryos. The Academy of Medical Sciences, London, UK (2007).
79. Kenyon L, Moraes CT: Expanding the functional human mitochondrial DNA database by the establishment of primate xenomitochondrial cybrids. Proc. Natl Acad. Sci. USA 94, 9131-9135 (1997).
80. Kim MK, Jang G, Oh HJ et al.: Endangered wolves cloned from adult somatic cells. Cloning Stem Cells 9, 130-137 (2007).
81. Solter D, Aronson J, Gilbert SF, McGrath J: Nuclear transfer in mouse embryos: activation of the embryonic genome. Cold Spring Harb. Symp. Quant. Biol. 50, 45-50, (1985).
82. Minger S: Interspecies SCNT-derived human embryos - a new way forward for regenerative medicine. Regenerative Med. 2, 103-106 (2007).
83. Biron-Shental T, Fisch B, Van Den HR et al.: Survival of frozen-thawed human ovarian fetal follicles in long-term organ culture. Fertil. Steril. 81, 716-719 (2004).
84. O'Brien MJ, Pendola JK, Eppig JJ: A revised protocol for in vitro development of mouse oacytes from primordial follicles dramatically improves their developmental competence. Biol. Reprod. 68, 1682-1686 (2003).
85. Hübner K, Fuhrmann G, Christenson LK et al.: Derivation of oocytes from mouse embryo'nic stem cells. Science 300, 1251-1256 (2003).
86. Simpson E, Roopenian D: Minor histocompatibility antigens. Curr. Opin. Immunol. 9, 655-661 (1997).
87. Vanikar AV, Mishra VV, Firoz A et al.: Successful generation of donor specific hematopoietic stem cell lines from co-cultured bone marrow with human embryonic stem cell line: a new methodology. Transplant. Proc. 39, 658-661 (2007).
88. Miller RA, Ruddle FH: Pluripotent teratocarcinoma-thymus somatic cell hybrids. Cell 9, 45-55 (1976).
89. Tada M, Tada T, Lefebvre L, Barton SC, Surani MA: Embryonic germ cells induce epigenetic reprogramming of somatic nucleus in hybrid cells. EMBO J. 16, 6510-6520 (1997).
90. Tada M, Takahama Y, Abe K, Nakatsuji N, Tada T: Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells. Curr. Biol. 11, 1553-1558 (2001).
91. Pells S, Di Domenico AI, Gallagher EJ, McWhir J: Multipotentiality of neuronal cells after spontaneous fusion with embryonic stem cells and nuclear reprogramming in vitro. Cloning Stem Cells 4, 331-338 (2002).
92. Cowan CA, Atienza J, Melton DA, Eggan K: Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells. Science 309, 1369-1373 (2005).
93. Yu J, Vodyanik MA, He P, Slukvin II, Thomson JA: Human embryonic stem cells reprogram myeloid precursors following cell-cell fusion. Stem Cells 24, 168-176 (2006).
94. Kimura H, Tada M, Nakatsuji N, Tada T: Histone code modifications on pluripotential nuclei of reprogrammed somatic cells. Mol. Cell Biol. 24, 5710-5720 (2004).
95. Silva J, Chambers I, Pollard S, Smith A: Nanog promotes transfer of pluripotency after cell fusion. Nature 441, 997-1001 (2006).
96. Blelloch R, Wang Z, Meissner A et al.: Reprogramming efficiency following somatic cell, nuclear transfer is influenced by the differentiation and methylation state of the donor nucleus. Stem Cells 24, 2007-2013 (2006).
97. Do JT, Schöler HR: Nuclei of embryonic stem cells reprogram somatic cells. Stem Cells 22, 941-949 (2004).
98. Strelchenko N, Kukharenko V, Shkumatov A et al.: Reprogramming of human somatic cells by embryonic stem cell cytoplast. Reprod. Biomed. Online. 12, 107-111 (2006).
99. Pralong D, Mrozik K, Occhiodoro F et al.: A novel method for somatic cell nuclear transfer to mouse embryonic stem cells. Cloning Stem Cells 7, 265-271 (2005).
100. Matsumura H, Tada M, Otsuji T et al.: Targeted chromosome elimination from ES-somatic hybrid cells. Nat. Methods 4, 23-25 (2007).
101. De Robertis EM, Gurdon JB: Gene activation in somatic nuclei after injection into amphibian oocytes. Proc. Natl Acad. Sci. USA 74, 2470-2474 (1977).
102. McGann CJ, Odelberg SJ, Keating MT: Mammalian myotube dedifferentiation induced by newt regeneration extract. Proc. Natl Acad. Sci. USA 98, 13699-13704 (2001).
103. Håkelien AM, Landsverk HB, Robl JM, Skalhegg BS, Collas P: Reprogramming fibroblasts to express T-cell functions using cell extracts. Nat. Biotechnol. 20, 460-466 (2002).
104. Gaustad KG, Boquest AC, Anderson BE, Gerdes AM, Collas P: Differentiation of human adipose tissue stem cells using extracts of rat cardiomyocytes. Biochem. Biophys. Res. Commun. 314, 420-427 (2004).
105. Håkelien AM, Gaustad KG, Collas P: Transient alteration of cell fate using a nuclear and cytoplasmic extract of an insulinoma cell line. Biochem. Biophys. Res. Commun. 316, 834-841 (2004).
106. Qin M, Tai G, Collas P, Polak JM, Bishop AE: Cell extract-derived differentiation of embryonic stem cells. Stem Cells 23, 712-718 (2005).
107. Håkelien AM, Gaustad KG, Taranger CK et al.: Long-term in vitro, cell-type-specific genome-wide reprogramming of gene expression. Exp. Cell Res. 309, 32-47 (2005).
108. Taranger CK, Noer A, Sorensen AL et al.: Induction of dedifferentiation, genomewide transcriptional programming, and epigenetic reprogramming by extracts of carcinoma and embryonic stem cells. Mol. Biol. Cell 16, 5719-5735 (2005).
109. Freberg CT, Dahl JA, Timoskainen S, Collas P: Epigenetic reprogramming of OCT4 and NANOG regulatory regions by embryonal carcinoma cell extract. Mol. Biol. Cell 18, 1543-1553 (2007).
110. Simonsson S, Gurdon J: DNA demethylation is necessary for the epigenetic reprogramming of somatic cell nuclei. Nat. Cell Biol. 6, 984-990 (2004).
111. Laursen SB, Møllgaard K, Olesen C et al.: Regional differences in expression of specific markers for human embryonic stem cells. Reprod. Biomed. Online.15, 89-98 (2007).
112. Hansis C, Barreto G, Maltry N, Niehrs C: Nuclear reprogramming of human somatic cells by xenopus egg extract requires BRG1. Curr. Biol. 14, 1475-1480 (2004).
113. Gurdon JB: From nuclear transfer to nuclear reprogramming: the reversal of cell differentiation. Annu. Rev. Cell Dev. Biol. 22, 1-22 (2006).
114. Oliveri RS, Kalisz M, Schjerling CK et al.: Evaluation in mammalian oocytes of gene transcripts linked to epigenetic reprogramming. Reproduction (2007) (In press).
115. Gan Q, Yoshida T, McDonald OG, Owens GK: Epigenetic mechanisms contribute to pluripotency and cell lineage determination of embryonic stem cells. Stem Cells 25, 2-9 (2007).
116. Kang YK, Park JS, Koo DB et al.: Limited demethylation leaves mosaic-type methylation states in cloned bovine pre-implantation embryos. EMBO J. 21, 1092-1100 (2002).
117. Ramchandani S, Bhattacharya SK, Cervoni N, Szyf M: DNA methylation is a reversible biological signal. Proc. Natl Acad. Sci. USA 96, 6107-6112 (1999).
118. Cervoni N, Bhattacharya S, Szyf M: DNA demethylase is a processive enzyme. J. Biol. Chem. 274, 8363-8366 (1999).
119. Hendrich B, Tweedie S: The methyl-CpG binding domain and the evolving role of DNA methylation in animals. Trends Genet. 19, 269-277 (2003).
120. Darr H, Benventsty N: Human embryonic stem cells: the battle between self-renewal and differentiation. Regenerative Med. 1, 317-325 (2006).
121. Niwa H: How is pluripotency determined and maintained? Development 134, 635-646 (2007).
122. Boyer LA, Lee TI, Cole MF et al.: Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122, 947-956 (2005).
123. Loh YH, Wu Q, Chew JL et al.: The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat. Genet. 38, 431-440 (2006).
124. Yamaguchi S, Kimura H, Tada M, Nakatsuji N, Tada T: Nanog expression in mouse germ cell development. Gene Expr. Patterns. 5, 639-646 (2005).
125. Nichols J, Zevnik B, Anastassiadis K et al.: Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95, 379-391 (1998).
126. Niwa H, Miyazaki J, Smith AG: Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat. Genet. 24, 372-376 (2000).
127. Cauffman G, Liebaers I, Van Steirteghem A, Van de Velde H: POU5F1 isoforms show different expression patterns in human embryonic stem cells and preimplantation embryos. Stem Cells 24, 2685-2691 (2006).
128. Zangrossi S, Marabese M, Broggini M et al.: Oct-4 expression in adult human differentiated cells challenges its role as a pure stem cell marker. Stem Cells 25(7), 1675-1680 (2007).
129. Chambers I, Colby D, Robertson M et al.: Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113, 643-655 (2003).
130. Mitsui K, Tokuzawa Y, Itoh H et al.: The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113, 631-642 (2003).
131. Ginis I, Luo Y, Miura T et al.: Differences between human and mouse embryonic stem cells. Dev. Biol. 269, 360-380 (2004).
132. Okumura-Nakanishi S, Saito M, Niwa H, Ishikawa F: Oct-3/4 and Sox2 regulate Oct-3/4 gene in embryonic stem cells. J. Biol. Chem. 280, 5307-5317 (2005).
133. Rodda DJ, Chew JL, Lim LH et al.: Transcriptional regulation of nanog by OCT4 and SOX2. J. Biol. Chem. 280, 24731-24737 (2005).
134. Graham V, Khudyakov J, Ellis P, Pevny L: SOX2 functions to maintain neural progenitor identity. Neuron 39, 749-765 (2003).
135. Avilion AA, Nicolis SK, Pevny LH et al.: Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev. 17, 126-140 (2003).
136. Takahashi K, Yamanaka S: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676 (2006).
137. Toma JG, Akhavan M, Fernandes KJ et al.: Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nat. Cell Biol. 3, 778-784 (2001).
138. Toma JG, McKenzie IA, Bagli D, Miller FD: Isolation and characterization of multipotent skin-derived precursors from human skin. Stem Cells 23, 727-737 (2005).
139. Martin MJ, Muotri A, Gage F, Varki A: Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nat. Med. 11, 228-232 (2005).
140. Klimanskaya I, Chung Y, Meisner L et al.: Human embryonic stem cells derived without feeder cells. Lancet 365, 1636-1641 (2005).
141. Ludwig TE, Levenstein ME, Jones JM et al.: Derivation of human embronic stem cells in defined conditions. Nat. Biotechnol. 24(2), 185-187 (2006).
142. Rajala K, Hakala H, Panula S et al.: Testing of nine different xeno-free culture media for human embryonic stem cell cultures. Hum. Reprod. 22(5), 1231-1238 (2007).
143. Maitra A, Arking DE, Shivapurkar N et al.: Genomic alterations in cultured human embryonic stem cells. Nat. Genet. 37, 1099-1103 (2005).
144. Halme DG, Kessler DA: FDA regulation of stem-cell-based therapies. N. Engl. J. Med. 355, 1730-1735 (2006).
145. Strachan T, Read AP: Human Molecular Genetics 2. Bios Scientific, Oxford, UK (1999).